News

The TSC Alliance has partnered with DiRx, an online digital pharmacy platform focused on generic medicine access and affordability.  This program utilizes generic formulations of medications on a cash basis only. For those who struggle with access or delays due to insurance or prior authorization, this program may offer an alternative.  Medications that require Risk Evaluation and Mitigation Strategies (REMS), such as vigabatrin, are currently not available through this program.   DiRx will offer industry-lowest prices on generic medications commonly used by patients with TSC manifestations, including seizures. TSC patients with a valid U.S. prescription will be able to save as much as 79% over average retail on two commonly prescribed drugs for this condition, Everolimus and Sirolimus, and benefit from free U.S. shipping, with no insurance required.  To find out more or if you have any questions, please contact DiRx customer service at 1-877-367-3479.